Sort
11,323 grants matching “glioblastoma”
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
$587,142Benjamin M. Ellingson · University Of California Los Angeles · R01 · FY2024 · CA
Angiogenesis imaging
$587,050Peter L. Choyke · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
MR Metabolic Imaging of Response to Targeted Therapies in GBM
$586,859Sabrina Miriam Ronen · University Of California, San Francisco · R01 · FY2012 · CA
Radiomic spatial maps for identifying viable tumor extent on multi-parametric MRI for Glioblastoma
$586,765Pallavi Tiwari · University Of Wisconsin-Madison · R01 · FY2025 · CA
Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1
$586,658Aristotelis Tsirigos · New York University School Of Medicine · R01 · FY2024 · CA
Metabolism and Epigenetics
$586,588Jasper D Rine · University Of California Berkeley · R01 · FY2016 · GM
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas
$586,565Richard J Price · University Of Virginia · R01 · FY2022 · EB
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
$586,523David M. Ashley · Duke University · U19 · FY2023 · CA
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$586,386Kit S Lam · University Of California At Davis · U01 · FY2017 · CA
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$586,386Kit S Lam · University Of California At Davis · U01 · FY2018 · CA
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$586,386Kit S Lam · University Of California At Davis · U01 · FY2016 · CA
Project 1: DNA Methylation-Based Blood Biomarkers for Prognosis, Molecular Stratification and Treatment Response in Glioma Patients
$586,159Annette M Molinaro · University Of California, San Francisco · P50 · FY2023 · CA
Oncolytic Immunotherapy using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
$586,155James M Markert · University Of Alabama At Birmingham · R01 · FY2018 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$585,861Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
$585,583Ana Krtolica · Omniox, Inc. · R01 · FY2018 · CA
Imaging Guided Genomics of Malignant Transformation
$585,461Joseph F Costello · University Of California, San Francisco · R01 · FY2017 · CA
Project 1: Design Rules for Spherical Nucleic Acids that Target Cancer
$585,205Milan Mrksich · Northwestern University At Chicago · U54 · FY2017 · CA
Tumor-Associated Macrophages in Vasogenic Cerebral Edema in Brain Tumors
$585,044Dolores Hambardzumyan · University Of Pennsylvania · R01 · FY2025 · NS
Resistance To Therapeutics Directed At The EGFR/Pi3-K Pathways In Glioblastoma
$584,993Webster Cavenee · Dana-Farber Cancer Inst · P01 · FY2011 · CA
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$584,839Kit S Lam · University Of California At Davis · U01 · FY2015 · CA
Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy
$584,463John H Sampson · Duke University · R01 · FY2020 · CA
Molecular and structural mechanisms of mTORC1 regulation in cancer
$584,036James H Hurley · University Of California Berkeley · R01 · FY2024 · CA
Molecular and structural mechanisms of mTORC1 regulation in cancer
$584,036James H Hurley · University Of California Berkeley · R01 · FY2025 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis
$583,998Sarah J. Nelson · University Of California, San Francisco · P01 · FY2017 · CA
Improving the efficacy of mTOR inhibition
$583,883William A Weiss · University Of California, San Francisco · R01 · FY2018 · CA